The role of regulatory T cells in malignant glioma
- PMID: 18505050
The role of regulatory T cells in malignant glioma
Abstract
The aggressive nature of gliomas is closely related to their capacity to evade the anti-tumoral immune response. The mechanisms implicated in this phenomenon are only partially understood. A subset of T cells, termed CD4+ CD25+ regulatory T cells (Treg), have been shown to inhibit the actions of effector lymphocytes. These Tregs are increased in the blood and tumors of glioma patients and animals with experimental brain tumors. Moreover, tumor infiltration by Tregs correlates with tumor grade and in animal models, depletion of Tregs is associated with prolonged survival. This review focuses on the role of Tregs in the immune suppression exhibited by malignant gliomas. The biology of these cells is briefly described in this context and finally, potential therapeutic strategies related to Treg ablation are explored.
Similar articles
-
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.Clin Cancer Res. 2008 Aug 15;14(16):5166-72. doi: 10.1158/1078-0432.CCR-08-0320. Clin Cancer Res. 2008. PMID: 18698034
-
Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.J Neurosurg. 2006 Sep;105(3):430-7. doi: 10.3171/jns.2006.105.3.430. J Neurosurg. 2006. PMID: 16961139
-
The role of regulatory T-cells in glioma immunology.Clin Neurol Neurosurg. 2014 Apr;119:125-32. doi: 10.1016/j.clineuro.2013.12.004. Epub 2014 Jan 3. Clin Neurol Neurosurg. 2014. PMID: 24582432 Review.
-
[Antitumor immune response: what are the roles for gliomas?].Rev Neurol (Paris). 2001 Nov;157(11 Pt 1):1339-48. Rev Neurol (Paris). 2001. PMID: 11924003 Review. French.
-
Prognostic significance and mechanism of Treg infiltration in human brain tumors.J Neuroimmunol. 2010 Aug 25;225(1-2):195-9. doi: 10.1016/j.jneuroim.2010.05.020. J Neuroimmunol. 2010. PMID: 20537408
Cited by
-
Natural killer cells in the brain tumor microenvironment: Defining a new era in neuro-oncology.Surg Neurol Int. 2019 Mar 26;10:43. doi: 10.25259/SNI-97-2019. eCollection 2019. Surg Neurol Int. 2019. PMID: 31528381 Free PMC article. No abstract available.
-
Advances in NK cell therapy for brain tumors.NPJ Precis Oncol. 2023 Feb 15;7(1):17. doi: 10.1038/s41698-023-00356-1. NPJ Precis Oncol. 2023. PMID: 36792722 Free PMC article. Review.
-
Immunohistochemical evaluation of immune cell infiltration in canine gliomas.Vet Pathol. 2021 Sep;58(5):952-963. doi: 10.1177/03009858211023946. Epub 2021 Jul 1. Vet Pathol. 2021. PMID: 34196247 Free PMC article.
-
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.Invest New Drugs. 2015 Apr;33(2):357-70. doi: 10.1007/s10637-014-0192-4. Epub 2014 Dec 23. Invest New Drugs. 2015. PMID: 25529192 Free PMC article. Clinical Trial.
-
Perspectives on the immunologic microenvironment of astrocytomas.Cancer Manag Res. 2013 Aug 30;5:293-9. doi: 10.2147/CMAR.S48942. eCollection 2013. Cancer Manag Res. 2013. PMID: 24039448 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials